Mohamad is a General Partner and heads NEA’s Healthcare Services and Healthcare Information Technology investment practice. Mohamad first joined NEA as an intern in 2000 and later as an associate in 2005. He is currently a Director of Aetion, American Pathology Partners, Bright Health, Collective Health, Curisium, Docent Health, Nuvolo, Pager, Radiology Partners, SCI Solutions, U.S. Renal Care, and Welltok. Mohamad’s past investments include Bravo Health, CHG Healthcare, DaVita NephroLife, DSI Renal, Long Term Care Group, ppoNEXT, and Vantage Oncology.
Previously, Mohamad focused on growth equity investments at Summit Partners prior to which he worked with UBS Investment Bank where he concentrated on leveraged finance and sponsor-led transactions. Mohamad received a bachelor’s degree, with distinction, from the University of Pennsylvania and is an active participant in the cancer community having been a founding board member of Livestrong’s Young Leadership Cancer Council.